Active, not recruitingPhase 2NCT06260709
A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis
Studying Amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novo Nordisk A/S
- Principal Investigator
- Clinical Transparency (dept. 2834)Novo Nordisk A/S
- Intervention
- NNC6019-0001(drug)
- Enrollment
- 80 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2024 – 2028
Study locations (30)
- Mayo Clinic Arizona, Phoenix, Arizona, United States
- Cedars-Sinai Medical Center_Los Angeles, Los Angeles, California, United States
- Stanford Hlth Cre-Boswell Clin, Stanford, California, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- NW Univ-Bluhm Cardiovasc Inst, Chicago, Illinois, United States
- NW Univ-Bluhm Cardiovasc Inst, Evanston, Illinois, United States
- Univ of MD Schl of Med, Baltimore, Maryland, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
- University of Calgary_Cardiology, Calgary, Alberta, Canada
- Ctr for Cardiovascular Innovation, Vancouver, British Columbia, Canada
- II. interni klinika VFN - Kardiologie a angiologie, Prague, Czechia
- Ap-Hp-Hopital Henri Mondor, Créteil, France
- Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1, Toulouse, France
- UniklinikHeidelberg - Innere Med. III - Kardiologie, Angiologie, Pneumologie, Heidelberg, Germany
- Universitätsklinik Heidelberg Innere Medizin III Kardiologie, Angiologie, Pneumologie, Heidelberg, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06260709 on ClinicalTrials.govOther trials for Amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07560306[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid CardiomyopathyBrigham and Women's Hospital
- RECRUITINGNCT07494656A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in GermanyPfizer
- RECRUITINGPHASE2NCT07285044The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo Clinic
- RECRUITINGNCT07218705A Study Of MCG In Cardiac AmyloidosisMayo Clinic
- ENROLLING BY INVITATIONPHASE2NCT06723015Tau PET Outcomes With Anti-amyloid ImmunotherapiesMayo Clinic
- RECRUITINGNCT07213297Comprehensive Program for Hereditary Transthyretin AmyloidosisHospital de Alta Complejidad en Red
- RECRUITINGPHASE1NCT06790394Test-retest Study With [18F]FBB in Cardiac AmyloidosisLife Molecular Imaging GmbH
- RECRUITINGNANCT07112066Multimodality Cardiac Imaging for Disease Progression in ATTR-CMDominik Benz